Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidiform mole: comparison between complete and partial mole

被引:31
作者
Matsui, H [1 ]
Iitsuka, Y [1 ]
Suzuka, K [1 ]
Seki, K [1 ]
Sekiya, S [1 ]
机构
[1] Chiba Univ, Sch Med, Dept Obstet & Gynecol, Chuo Ku, Chiba 2608670, Japan
关键词
gestational trophoblastic tumour; molar pregnancy; pregnancy outcome;
D O I
10.1093/humrep/16.6.1274
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This study compared subsequent pregnancy outcome in patients with complete and partial hydatidiform moles, Among 1052 patients with molar pregnancy (complete mole, 801; partial mole, 251) monitored at Chiba University Hospital between 1981 and 1999, 891 patients (84.7%) had spontaneous resolution of human chorionic gonadotrophin (HCG) after mole evacuation, and 161 patients (15.3%) required chemotherapy, Of the 891 patients, 438 (49.2%) had 650 subsequent pregnancies. The pregnancy outcome was not significantly different in patients with complete and partial moles, and was comparable with that in the general Japanese population. The incidence of repeat molar pregnancy in patients with complete and partial mole (1.3 and 1.5% respectively) was S-fold higher than that of the general population, while no increased risk of persistent gestational trophoblastic tumour (GTT) associated with later molar pregnancy was observed, During HCG follow-up, 10 patients (1.1%) developed secondary highrisk GTT between 14 and 54 months after mole evacuation. The incidence of high-risk GTT in patients with and without subsequent pregnancies was 0.46% (2/438) and 1.8% (8/453) respectively (P = 0.1243), In conclusion, patients with complete and partial mole can anticipate a normal future reproductive outcome, and pregnancies after experiencing hydatidiform mole may not affect the development of high-risk GTT.
引用
收藏
页码:1274 / 1277
页数:4
相关论文
共 18 条
[1]  
BAGSHAWE KD, 1986, LANCET, V2, P673
[2]  
Berkowitz RS, 1998, J REPROD MED, V43, P81
[3]  
BERKOWITZ RS, 1994, J REPROD MED, V39, P228
[4]  
FEDERSCHNEIDER JM, 1980, OBSTET GYNECOL, V55, P457
[5]   TREATMENT OF METASTATIC TROPHOBLASTIC DISEASE - GOOD AND POOR PROGNOSIS [J].
HAMMOND, CB ;
BORCHERT, LG ;
TYREY, L ;
CREASMAN, WT ;
PARKER, RT .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1973, 115 (04) :451-457
[6]   Subsequent reproductive experience after treatment for gestational trophoblastic disease [J].
Kim, JH ;
Park, DC ;
Bae, SN ;
Namkoong, SE ;
Kim, SJ .
GYNECOLOGIC ONCOLOGY, 1998, 71 (01) :108-112
[7]   Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Heath Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society [J].
Kohorn, EI ;
Goldstein, DP ;
Hancock, BW ;
Kim, SJ ;
Lurain, JR ;
Newlands, E ;
Soper, JT ;
Wong, LC .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (01) :84-88
[8]   How soon is it safe to undertake pregnancy after trophoblastic tumor? [J].
Kohorn, EI .
GYNECOLOGIC ONCOLOGY, 1999, 73 (03) :343-344
[9]   Incidence of invasive mole and choriocarcinoma following partial hydatidiform mole [J].
Matsui, H ;
Iizuka, Y ;
Sekiya, S .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1996, 53 (01) :63-64
[10]   Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors [J].
Matsui, H ;
Suzuka, K ;
Iitsuka, Y ;
Seki, K ;
Sekiya, S .
GYNECOLOGIC ONCOLOGY, 2000, 78 (01) :28-31